Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
39
AKBA Quote, Financials, Valuation and Earnings
Last price:
$1.84
Seasonality move
:
7.91%
Day range:
$1.75 - $1.87
52-week range:
$0.80 - $2.48
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.20x
P/B ratio:
--
Volume:
5.9M
Avg. volume:
2.2M
1-year change:
52.92%
Market cap:
$400.4M
Revenue:
$194.6M
EPS (TTM):
-$0.23
Akebia Therapeutics Number of Insider Trades
Akebia Therapeutics Volume of Insider Trades
Number of Insiders Buying
0
(Last 3 Months)
Number of Insiders Buying
16
(Last 6 Months)
Current Insider Ownership Percentage
3.62%
Number of Insiders Selling
0
(Last 3 Months)
Number of Insiders Selling
3
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Akebia Therapeutics Insider Trading
-
How Much of AKBA Stock is Owned By Insiders?
3.62% of Akebia Therapeutics stock is owned by insiders.
-
Have Insiders Have Been Buying or Selling AKBA Stock?
Yes, insiders have been buying 0 shares of AKBA stock for a value of --. Insiders have also been selling 0 shares of AKBA for a total of -- over the last 3 months.
-
How Much AKBA Stock was Sold by Insiders Last Quarter?
Over the last quarter, 0 shares of AKBA were sold by insiders for a total value of --.
-
How Much AKBA Stock was Bought by Insiders Last Quarter?
AKBA insiders bought -- worth of stock representing 0 shares.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
